Article Text
Statistics from Altmetric.com
Advances in cognitive neuroscience make cosmetic neurology in some form inevitable and will give rise to extremely difficult ethical issues
Consider the following hypothetical case study. A well heeled executive walks into my cognitive neurology clinic because he is concerned that he is becoming forgetful. It turns out that he is going through a difficult divorce and my clinical impression is that his memory problems stem from the stress he is experiencing. I place him on a selective seratonin reuptake inhibitor, sertraline, and in a few weeks he feels better. Around this time his 13 year old daughter has difficulty at school and is diagnosed by the school psychologist as having attention deficit disorder. I place her on adderall, a stimulant combination drug, which seems to help with her behaviour in school. My patient then comes to me because he is experiencing the “tip of the tongue” phenomena more frequently. He is concerned that his word finding difficulty interferes with his ability to function in high level meetings. I suggest we try a cholinesterase inhibitor to see if this helps. I am careful to explain that the Food and Drug Administration does not approve such a use for this medication. He wants to try it and is pleased with the results.
A few months later, this patient visits me with his 16 year old son, a talented middle distance runner. His father thinks if he were just a bit better, among the elite high school runners in the state, he would be far more competitive as an applicant for selective colleges. We discuss various options. Because of a recent report that sildenafil, which is used conventionally for male impotence, may improve oxygen carrying capacity, I prescribe this medication. The son does not object.
Encouraged by these pharmacologic successes, my patient …
Footnotes
-
↵i Evolutionary biologists use the Red Queen principle to describe pressures for survival among co-evolving species.
Read the full text or download the PDF:
Other content recommended for you
- Western Regional Meeting Abstracts
- Polymorphisms in the IGF1 signalling pathway including the myostatin gene are associated with left ventricular mass in male athletes
- Recreational and ergogenic substance use and substance use disorders in elite athletes: a narrative review
- Research based recommendations on management of sport related concussion: summary of the National Athletic Trainers’ Association position statement
- Claims for the anabolic effects of growth hormone: a case of the Emperor’s new clothes?
- 2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad: 1st International Conference held in San Francisco, California, May 2012 and 2nd International Conference held in Indianapolis, Indiana, May 2013
- Determination and regulation of body composition in elite athletes
- Effects of an endurance cycling competition on resting serum insulin-like growth factor I (IGF-I) and its binding proteins IGFBP-1 and IGFBP-3
- IOC consensus statement on relative energy deficiency in sport (RED-S): 2018 update
- What domains of clinical function should be assessed after sport-related concussion? A systematic review